Detalles de la búsqueda
1.
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Br J Cancer
; 113(12): 1704-11, 2015 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26645239
2.
SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).
Future Oncol
; 11(7): 1027-36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25804118
3.
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis.
Oncol Res Treat
; 46(3): 100-105, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754037
4.
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy.
J Immunother Cancer
; 9(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789880
5.
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.
Ther Adv Med Oncol
; 13: 1758835921996506, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34104223
6.
Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma.
Cancer Manag Res
; 11: 8711-8720, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31576173
7.
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget
; 8(23): 37502-37510, 2017 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28415584
8.
miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma.
Virchows Arch
; 470(6): 627-637, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466156
9.
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
Oncotarget
; 7(15): 20166-79, 2016 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27064343
10.
microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma.
Oncotarget
; 7(14): 18713-21, 2016 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26918730
11.
ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.
PLoS One
; 11(11): e0165181, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27802291
12.
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy.
J Cancer
; 7(13): 1915-1925, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698933
13.
Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.
Oncotarget
; 6(28): 24690-8, 2015 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26008974
14.
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours.
J Cancer
; 5(8): 646-54, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25157275
15.
Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer.
Eur J Cancer
; 49(11): 2461-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23692812
Resultados
1 -
15
de 15
1
Próxima >
>>